Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rectal Neoplasms × Ondansetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 22 Nausea 19 Neoplasms 6 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Acute 4 Burkitt Lymphoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Sezary Syndrome 3 Primary Myelofibrosis 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Hairy Cell 3 Hodgkin Disease 3 Carcinoma, Ovarian Epithelial 3 Blast Crisis 3 Testicular Neoplasms 2 Recurrence 2

Interventions

Fluorouracil 142 Oxaliplatin 121 Leucovorin 115 Capecitabine 82 Irinotecan 79 Radiotherapy 58 Bevacizumab 54 Cetuximab 33 Folfox protocol 24 Panitumumab 20 Neoadjuvant Therapy 20 Surgical Procedures, Operative 17 Chemotherapy, Adjuvant 15 Radiation 13 Floxuridine 13 Erlotinib Hydrochloride 12 Early Intervention, Educational 11 Proctectomy 10 IFL protocol 10 Drug Therapy 10 Counseling 10 Psychiatric Rehabilitation 8 Magnetic Resonance Spectroscopy 8 Surveys and Questionnaires 7 Immunohistochemistry 7 Celecoxib 7 aflibercept 6 Sorafenib 6 Radiotherapy, Intensity-Modulated 6 Methods 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03182179 2022-10-17

Hodolar

Ente Ospedaliero Cantonale, Bellinzona

Phase NA Completed

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡